We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other Renaissance Technologies portfolio’s top stock picks. The American quant hedge ...

In a post-Operation Transformation world, Kathryn Thomas' priorities haven't changed. The TV presenter still strives to help people feel and look their best in the safest and healthiest way possible, ...

Senoia, Ga. — Reverend Stuart Ashby Kersey, Jr., 97 of Senoia, Georgia, and formerly of Gaffney, SC, passed away Sunday, February 16, at Fayetteville Center for Nursing and Healing. He was born ...

Reverend Stuart Ashby Kersey, Jr., 97 of Senoia, Georgia, and formerly of Gaffney, SC, passed away Sunday, Feb.16, at Fayetteville Center for Nursing and Healing. He was born Dec. 12, 1927 in Richmond ...

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir-the company’s twice-yearly ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--#GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health ...

Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, and downgraded Merck (NYSE:MRK), citing the cancer drugmaker’s ...

(RTTNews) - Gilead Sciences (GILD) announced that the FDA has accepted its New Drug Application submissions for lenacapavir-the twice-yearly injectable HIV-1 capsid inhibitor-for the prevention of ...

16 analysts have shared their evaluations of Gilead Sciences GILD during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of ...